Fibromyalgia Syndrome Subgroups

REFERENCES

• Kogstad O. Primary fibromyalgia syndrome-subgroups of inflammatory rheumatic nature? [letter]. Scandinavian Journal of Rheumatology 1988; 17, 154
   Google Scholar
• Graven-Nielsen T, Aspegren K S, Henriksson K G, Bengtsson M, Sorensen J, Johnson A, Gerdle B, Arendt-Nielsen L. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000; 85: 483–491
   PubMed Web of Science ®Google Scholar
• Sorensen J, Bengtsson A, Ahlner J, Henriksson K G, Ekselius L. Fibromy-algia—Are there different mechanisms in the processing of pain? A double-blind crossover comparison of analgesic drugs. J Rheumatol 1997; 24: 1615–1621
   PubMed Web of Science ®Google Scholar
• Giovengo S L, Russell I J, Larson A A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. Journal of Rheumatology 1999; 26: 1564–1569
   PubMed Web of Science ®Google Scholar
• Walen H R, Cronan T A, Serber E R, Groessl E, Oliver K. Subgroups of fibromyalgia patients: Evidence for heterogeneity and an examination of differential effects following a community-based intervention. J Musculoske Pain 2002; 10(3)9–32
   Web of Science ®Google Scholar
• Mueller H H, Donaldson C CS, Nelson D V, Layman M. Treatment of fibromyalgia incorporating EEG-driven stimulation: A clinical outcomes study. Journal of Clinical Psychology 2001; 57: 933–952
   PubMed Web of Science ®Google Scholar
• Russell I J, Orr M D, Littman B, Vipraio G A, Alboukrek D, Michalek J E, Lopez Y, MacKillip F. Elevated cerebrospinal levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593–1601
   PubMed Web of Science ®Google Scholar
• Wilson R B, Gluck O S, Tesser J R, Rice J C, Meyer A, Bridges A J. Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity. Journal of Rheumatology 1999; 26: 402–407
   PubMed Web of Science ®Google Scholar
• Donaldson M, Donaldson C CS, Mueller H H, Sella G. QEEG patterns, psychological status, and pain reports of fibromyalgia sufferers. Am J Pain Management 2002, [Submitted]
   Google Scholar
• Hadler N M. A critical reappraisal of the fibrositis concept. Am J Med 1986; 81: 26–30
   PubMed Web of Science ®Google Scholar
• Hadler N M. Fibromyalgia, chronic fatigue, and other iatrogenic diagnostic algorithms: Do some labels escalate illness in vulnerable patients?. Postgraduate Medicine 1997; 102(2)161–177
   PubMed Web of Science ®Google Scholar
• Hadler N M. If you have to prove you are ill, you can't get well. The object lesson of fibromyalgia. [Review] [32 refs]. Spine 1996; 21: 2397–2400
   PubMed Web of Science ®Google Scholar
• Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997; 56: 268–271
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum, 33: 160–172, 1990
   PubMed Web of Science ®Google Scholar
• Smythe H A, Moldofsky H. Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 1977; 28: 928–93l
   PubMedGoogle Scholar
• Ahles T A, Khan S A, Yunus M B, Spiegel D A, Masi A T. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiat 1991; 148: 1721–1726
   PubMed Web of Science ®Google Scholar
• Aaron L A, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. [Review] [79 refs]. Annals of Internal Medicine 2001; 134: 868–881
   PubMed Web of Science ®Google Scholar
• Romano T J. Coexistence of irritable bowel syndrome and fibromyalgia. W V Med J 1988; 84: 16–18
   PubMedGoogle Scholar
• Veale D, Kavanagh G, Fielding J F, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheum 1991; 30: 220–222
   PubMedGoogle Scholar
• Yunus M B. Fibromyalgia syndrome: Clinical features and spectrum. J Mus-culoske Pain 1994; 2(3)5–21
   Google Scholar
• Alagiri M, Chottiner S, Ratner V, Slade D, Hanno P M. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997; 49: 52–57
   PubMed Web of Science ®Google Scholar
• Clauw D J, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. Journal of Psychiatric Research 1997; 31: 125–131
   PubMed Web of Science ®Google Scholar
• Acasuso-Diaz M, Collantes-Estevez E. Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care Res 1998; 11: 39–42
   PubMed Web of Science ®Google Scholar
• Gedalia A, Press J, Klein M, Buskila D. Joint hypermobility and fibromyalgia in schoolchildren. Ann Rheum Dis 1993; 52: 494–496
   PubMed Web of Science ®Google Scholar
• Goldman J A. Hypermobility and deconditioning: important links to fibro-myalgia/fibrositis. Southern Med J 1991; 84: 1192–1196
   PubMed Web of Science ®Google Scholar
• Goldman J A. Is fibrositis associated with hypermobility?. J Musculoske Med December 1985
   Google Scholar
• Tan E M, Cohen A S, Fries J F, et al. The 1992 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Hughes G RV. Systemic Lupus Erythematosus. Copeman's Textbook of the Rheumatic Diseases, Fifth Edition, J T Scott. T. & A. Constable Ltd, Edinburgh 1978; 901–922
   Google Scholar
• Rothfield N F. Systemic Lupus Erythematosus. Rheumatic Diseases; Diagnosis and Management, First Edition, W A Katz. J. B. Lippincott Company, Philadelphia 1977; 756–776
   Google Scholar
• Estes D, Christian C L. SLE A prospective analysis. Medicine 1971; 50, 85
   Google Scholar
• Giovengo S L, Russell I J, Larson A A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. Journal of Rheumatology 1999; 26: 1564–1569
   PubMed Web of Science ®Google Scholar
• Derogatis L. SCL-90-R: Administration, scoring, and procedures manual, Third Edition. Clinical Psychometric Research. 1994
   Google Scholar
• Sorensen J, Bengtsson A, Backman E, Henriksson K G, Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995; 24: 360–365
   PubMed Web of Science ®Google Scholar